<p>Blue, Day 34 (<i>N</i> = 2); red, Day 35 (<i>N</i> = 2); and green, Day 36 (<i>N</i> = 2). The intracellular TFV-DP levels are maintained 4–6 days after pod-IVR removal on Day 30. The box plots represent the analytical lower limits of quantitation (LLOQ) associated with the TFV-DP measurements, where the box extends from the 25th to 75th percentiles, with the horizontal line in the box representing the median; whiskers represent the lowest and highest datum. The assay has an LLOQ of 50 fmol per sample, which is divided by the number of cells collected in each sample to afford the individual LLOQs represented here.</p
Mucosal concentrations of TFV and TFV-DP based on community state type (CST) at end of treatment (vi...
CVF, cervicovaginal fluid; VT, vaginal tissue; RF, rectal fluid. Measurements outside of the analyti...
<p>Each set of figures documents the 30 min drug quantification in the left-side graph and the 24 hr...
<p>TFV-DP levels were measured by LC-MS/MS in purified cultures of EM (n = 4), CX (n = 7) and ECX (n...
(A) ARV drug and TFV-DP levels in vaginal biopsies collected on Day 7 within 30 min of pod-IVR remov...
(A) ARV drug and TFV-DP levels in vaginal biopsies collected on Day 7 within 30 min of pod-IVR remov...
<p>Intracellular TFV-DP and FTC-TP concentrations at 24 h and 3 days in vaginal, rectal, and lymphoi...
<p>The biopsy contains both epithelium and some stromal tissue (see text). Enema retention time is 5...
<p>Side-by-side boxplots of end-of-period visit data for all participants by anatomic site and dosin...
<p>TFV-DP levels were measured by LC-MS/MS in purified cultures of epithelial cells (n = 14), fibrob...
ARV drug levels in CVF fall off rapidly following IVR removal (grey arrow) but are quantifiable for ...
ARV drug levels in CVF fall off rapidly following IVR removal (grey arrow) but are quantifiable for ...
<p>Data from end-of-period visit showing median (interquartile range) by dosing regimen in common co...
<p>TFV-DP levels were measured by LC-MS/MS in polarized cultures of FRT epithelial cells treated wit...
<p>TFV-DP levels were measured by LC-MS/MS in increasing numbers of purified blood CD4<sup>+</sup> T...
Mucosal concentrations of TFV and TFV-DP based on community state type (CST) at end of treatment (vi...
CVF, cervicovaginal fluid; VT, vaginal tissue; RF, rectal fluid. Measurements outside of the analyti...
<p>Each set of figures documents the 30 min drug quantification in the left-side graph and the 24 hr...
<p>TFV-DP levels were measured by LC-MS/MS in purified cultures of EM (n = 4), CX (n = 7) and ECX (n...
(A) ARV drug and TFV-DP levels in vaginal biopsies collected on Day 7 within 30 min of pod-IVR remov...
(A) ARV drug and TFV-DP levels in vaginal biopsies collected on Day 7 within 30 min of pod-IVR remov...
<p>Intracellular TFV-DP and FTC-TP concentrations at 24 h and 3 days in vaginal, rectal, and lymphoi...
<p>The biopsy contains both epithelium and some stromal tissue (see text). Enema retention time is 5...
<p>Side-by-side boxplots of end-of-period visit data for all participants by anatomic site and dosin...
<p>TFV-DP levels were measured by LC-MS/MS in purified cultures of epithelial cells (n = 14), fibrob...
ARV drug levels in CVF fall off rapidly following IVR removal (grey arrow) but are quantifiable for ...
ARV drug levels in CVF fall off rapidly following IVR removal (grey arrow) but are quantifiable for ...
<p>Data from end-of-period visit showing median (interquartile range) by dosing regimen in common co...
<p>TFV-DP levels were measured by LC-MS/MS in polarized cultures of FRT epithelial cells treated wit...
<p>TFV-DP levels were measured by LC-MS/MS in increasing numbers of purified blood CD4<sup>+</sup> T...
Mucosal concentrations of TFV and TFV-DP based on community state type (CST) at end of treatment (vi...
CVF, cervicovaginal fluid; VT, vaginal tissue; RF, rectal fluid. Measurements outside of the analyti...
<p>Each set of figures documents the 30 min drug quantification in the left-side graph and the 24 hr...